AN ACT TO AMEND SECTION 73-25-33, MISSISSIPPI CODE OF 1972, TO PROVIDE THAT THE PRACTICE OF MEDICINE INCLUDES THE PRACTICE OF OBESITY MEDICINE; TO DEFINE OBESITY MEDICINE; TO AMEND SECTION 73-25-34, MISSISSIPPI CODE OF 1972, TO REVISE THE DEFINITION OF TELEMEDICINE TO INCLUDE THE PRACTICE OF MEDICINE BY A LICENSED PHYSICIAN AT A DISTANT SITE TO A PATIENT LOCATED AT AN ORIGINATING SITE USING HIPAA-COMPLIANT TELECOMMUNICATION SYSTEMS; TO AMEND SECTION 41-29-139, MISSISSIPPI CODE OF 1972, TO AUTHORIZE PHYSICIANS PRACTICING OBESITY MEDICINE TO PRESCRIBE LEGEND DRUGS, INCLUDING GLP-1 THERAPEUTICS, TO A PATIENT VIA TELEMEDICINE, SUBJECT TO THE CERTAIN CONDITIONS; TO DIRECT THE STATE BOARD OF MEDICAL LICENSURE TO ADOPT RULES AS NECESSARY TO IMPLEMENT THE PROVISIONS OF THIS ACT; AND FOR RELATED PURPOSES.
Impact
The enactment of HB1136 has the potential to significantly alter healthcare delivery for obesity management in Mississippi. By explicitly defining obesity medicine within the scope of licensed medical practice, the bill legitimizes and emphasizes the importance of treating obesity as a significant health issue. Furthermore, allowing prescriptions via telemedicine could improve access to obesity treatments, particularly for patients in rural areas who may have difficulty accessing specialist care.
Summary
House Bill 1136 aims to amend the Mississippi Code of 1972 by incorporating the practice of obesity medicine into the definition of medical practice. This bill defines obesity medicine as the medical specialization dedicated to the comprehensive care of patients suffering from obesity, which includes prescription-related activities. Notably, licensed physicians certified in obesity medicine are allowed to prescribe medications, including certain weight loss drugs, through telemedicine under specified conditions.
Contention
Opposition may arise regarding the provision of prescribing medications through telemedicine, particularly in the context of clinical oversight and patient safety. Concerns may be raised about the potential for misuse of prescription drugs and the adequacy of care that can be provided remotely. Additionally, there might be discussions surrounding the implications for continuity of care, and how telemedicine might affect patient relationships with their local healthcare providers.
Implementation
The bill mandates the State Board of Medical Licensure to adopt relevant rules within 180 days after its passage to ensure congruity with this act. The effective date of this act is July 1, 2026, which gives the Board time to prepare and implement the required regulations. This preparation phase is crucial for setting standards and guidelines that ensure the safe and ethical practice of obesity medicine via telemedicine in Mississippi.